Volume 75, Issue 2, Pages (February 2019)

Slides:

Advertisements

Similar presentations

Volume 50, Issue 3, Pages (September 2006)

Advertisements

Volume 59, Issue 2, Pages (February 2011)

Urinary Nerve Growth Factor Levels are Elevated in Patients with Detrusor Overactivity and Decreased in Responders to Detrusor Botulinum Toxin-A Injection

Volume 70, Issue 6, Pages (December 2016)

Volume 52, Issue 1, Pages (July 2007)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 70, Issue 1, Pages (July 2016)

Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: Results of a 24week, double-blind, randomized.

Jean-Jacques Wyndaele European Urology Supplements

Volume 54, Issue 6, Pages (December 2008)

Combination of Alfuzosin and Sildenafil is Superior to Monotherapy in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction Steven A. Kaplan,

Debra E. Irwin, Ian Milsom, Zoe Kopp, Paul Abrams European Urology

Volume 64, Issue 4, Pages (October 2013)

Volume 50, Issue 5, Pages (November 2006)

Volume 71, Issue 4, Pages (April 2017)

Volume 53, Issue 5, Pages (May 2008)

Let the Games Begin (with EAU Approval)

Volume 45, Issue 4, Pages (April 2004)

Volume 57, Issue 5, Pages (May 2010)

Volume 63, Issue 2, Pages (February 2013)

Volume 56, Issue 1, Pages (July 2009)

Volume 53, Issue 2, Pages (February 2008)

Volume 59, Issue 2, Pages (February 2011)

Volume 63, Issue 1, Pages (January 2013)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 56, Issue 3, Pages (September 2009)

Volume 59, Issue 4, Pages (April 2011)

Volume 62, Issue 3, Pages (September 2012)

Long-Term Management of Overactive Bladder with Antimuscarinic Agents

Prostate Cancer Detection: A View of the Future

Volume 51, Issue 3, Pages (March 2007)

Volume 64, Issue 5, Pages (November 2013)

P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes European Urology

Volume 64, Issue 4, Pages (October 2013)

Volume 55, Issue 3, Pages (March 2009)

Volume 70, Issue 1, Pages (July 2016)

Volume 56, Issue 1, Pages (July 2009)

Volume 70, Issue 1, Pages (July 2016)

Volume 52, Issue 4, Pages (October 2007)

James N. Armitage, Stuart O. Irving, Neil A. Burgess European Urology

Volume 69, Issue 2, Pages (February 2016)

Volume 65, Issue 2, Pages (February 2014)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

The Inside-Out Transobturator Male Sling for the Surgical Treatment of Stress Urinary Incontinence After Radical Prostatectomy: Midterm Results of a Single-Center.

Volume 70, Issue 6, Pages (December 2016)

The Economic Costs of Overactive Bladder in Germany

Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl European Urology

Volume 54, Issue 4, Pages (October 2008)

Volume 70, Issue 1, Pages (July 2016)

Volume 50, Issue 5, Pages (November 2006)

Volume 50, Issue 5, Pages (November 2006)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 51, Issue 2, Pages (February 2007)

Volume 74, Issue 5, Pages (November 2018)

Philip Toozs-Hobson, Pallavi Latthe European Urology Supplements

Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: Results of a 24week, double-blind, randomized.

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

Volume 74, Issue 3, Pages (September 2018)

Pharmacotherapy in Stress and Mixed Incontinence

European Urology is “Your” Journal

The Start-Up of the Platinum Journal: A Fascinating Challenge

A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee

Volume 74, Issue 4, Pages (October 2018)

Volume 55, Issue 3, Pages (March 2009)

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

Classification of Mixed Incontinence

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 75, Issue 2, Pages 274-282 (February 2019) Vibegron (RVT-901/MK-4618/KRP-114V) Administered Once Daily as Monotherapy or Concomitantly with Tolterodine in Patients with an Overactive Bladder: A Multicenter, Phase IIb, Randomized, Double-blind, Controlled Trial Henry D. Mitcheson, Suvajit Samanta, Karen Muldowney, Cathy A. Pinto, Beatriz de A. Rocha, Stuart Green, Nathan Bennett, Paul N. Mudd, Tara L. Frenkl European Urology Volume 75, Issue 2, Pages 274-282 (February 2019) DOI: 10.1016/j.eururo.2018.10.006 Copyright © 2018 Merck Sharp & Dohme Corp and The Authors Terms and Conditions

Fig. 1 Patient disposition. ER=extended release. European Urology 2019 75, 274-282DOI: (10.1016/j.eururo.2018.10.006) Copyright © 2018 Merck Sharp & Dohme Corp and The Authors Terms and Conditions

Fig. 2 Change from baseline in average daily number of (A) micturitions, (B) urgency episodes, (C) urgency urinary incontinence episodes, and (D) total incontinence episodes over 8 wk (part 1; least square mean±95% confidence interval). BL=baseline; ER=extended release; LS=least square. European Urology 2019 75, 274-282DOI: (10.1016/j.eururo.2018.10.006) Copyright © 2018 Merck Sharp & Dohme Corp and The Authors Terms and Conditions